Share this post on:

Name :
LPPR3 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
LPPR3 Rabbit Polyclonal antibody. Positive WB detected in K-562 cells, HL-60 cells. Observed molecular weight by Western-blot: 76 kDa

Tested applications :
ELISA, WB

Species reactivity :
Human; other species not tested.

Alternative names :
LPPR3 antibody; LPR3 antibody; PAP 2 like protein 2 antibody; PHP2 antibody; plasticity related gene 2 antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of LPPR3 recombinant protein (Accession Number: BC017295). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:200-1:2000

Background :
PRG2 represents plasticity-related gene 2

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alirocumab Cancer
Phospho-AMPK alpha 1 (Ser496) Rabbit pAb custom synthesis
CREB Antibody: CREB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to CREB. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Gardos- Channel